IP Library › Granted Patent US 7,115,719
Granted Patent B2
US 7,115,719 · App. 11/012,527 · Granted Oct 3, 2006

Formulations and methods for denaturing proteins

Assignee: Gentra Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,115,719
App. No.
11/012,527
Granted
Oct 3, 2006
Kind
B2
Abstract

Reagents, methods and kits for denaturation of protein are provided.

Claims (30)

1. A formulation for denaturing proteins comprising:

a lithium salt at a concentration of about 2.5–4.0 M,

an alcohol at a concentration of about 25–40% v/v, and

a citrate at a concentration of about 25–100 mM.

2. The formulation of claim 1 , which formulation lacks EDTA.

3. The formulation of claim 1 , wherein the formulation lacks a chaotropic substance.

4. The method of claim 3 , wherein the chaotropic substance is guanidinium salt, urea, ammonium, cesium, rubidium, potassium, or iodide salt.

5. The formulation of claim 1 , wherein the lithium salt is lithium chloride or lithium bromide.

6. The formulation of claim 1 , wherein the lithium salt is lithium chloride.

7. The formulation of claim 1 , wherein the lithium salt is at a concentration of about 3.5 M.

8. The formulation of claim 1 , wherein the alcohol is ethanol or methanol.

9. The formulation of claim 1 , wherein the alcohol is ethanol.

10. The formulation of claim 1 , wherein the alcohol is at a concentration of about 30% alcohol.

11. The formulation of claim 1 , wherein the citrate is trisodium citrate.

12. The formulation of claim 1 , wherein the citrate is at a concentration of about 50 mM.

13. The formulation of claim 1 , wherein the formulation has a pH between about 6 and about 8.

14. The formulation of claim 1 , wherein the solution has a pH between about 7.0 and about 7.5.

15. A method for denaturing protein from a solid support, comprising contacting the solid support with the formulation of claim 1 , such that protein present on the solid support is denatured.

16. The method of claim 15 , wherein the protein is an enzyme.

17. The method of claim 16 , wherein the enzyme is a DNase.

18. The method of claim 17 , wherein the DNase is DNase I.

19. The method of claim 15 , wherein the solid support comprises components of silica, cellulose, cellulose acetate, nitrocellulose, nylon, polyester, polyethersulfone, polyolefin, or polyvinylidene fluoride, or combinations thereof.

20. The method of claim 15 , wherein the solid support is contained in a vessel, wherein the vessel is a centrifuge tube, spin tube, syringes, cartridge, chamber, multiple-well plate, or test tube, or combinations thereof.

21. A method for purifying substantially pure and undegraded RNA from biological material comprising RNA, comprising the steps of:

(a) contacting a solid support with the formulation of claim 1 , such that protein present on the solid support is denatured;

(b) contacting the solid support with a sample comprising RNA such that the RNA binds to the solid support;

(c) washing the solid support with a series of wash solutions to remove biological materials other than bound RNA, wherein the series of wash solutions comprises a first wash containing alcohol and an RNA-complexing salt at a concentration of at least 1M and a second wash containing an alcohol, buffer and an optional chelator; and

(d) preferentially eluting the bound RNA from the solid support with an RNA elution solution in order to obtain substantially pure RNA.

22. The method of claim 21 , wherein the solid support is contained in a vessel, wherein the vessel is a centrifuge tube, spin tube, syringe, cartridge, chamber, multiple-well plate, test tube, or combination thereof.

23. The method of claim 21 , wherein the RNA-complexing salt is lithium chloride.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2007
From: GENTRA SYSTEMS INC.
To: QIAGEN NORTH AMERICAN HOLDINGS, INC
Reel/Frame 019241/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2005
From: PAULSEN, KIM E.
To: GENTRA SYSTEMS, INC.
Reel/Frame 016073/0017 →
Continuity (2)
Provisional Application 6053039200 · Dec 16, 2003
Related Publication 20050171333A1 · Aug 4, 2005